Explore the words cloud of the GD TCR LIGAND project. It provides you a very rough idea of what is the project "GD TCR LIGAND" about.
The following table provides information about the project.
UNIVERSITE LIBRE DE BRUXELLES
|Coordinator Country||Belgium [BE]|
|Total cost||160˙800 €|
|EC max contribution||160˙800 € (100%)|
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
|Duration (year-month-day)||from 2017-03-01 to 2019-02-28|
Take a look of project's partnership.
|1||UNIVERSITE LIBRE DE BRUXELLES||BE (BRUXELLES)||coordinator||160˙800.00|
'gd T cells are the prototype of unconventional T cells and play an important role in the protection against infections and cancer. The group of David Vermijlen has recently discovered a human Vg8Vd1 T cell receptor (TCR) which was highly enriched in every individual (therfore 'public') infected in utero with human cytomegalovirus (HCMV), and that reacts towards adult cancer cells, suggesting that it can detect signals of 'cellular stress' induced in both infections and cell transformation. The major aim of this project is the identification of the ligand of this cross-reactive public Vg8Vd1 TCR. Two strategies will be adopted to address this aim. In the first strategy (indirect approach), a list of candidate ligands will be tested for the capacity to stimulate the TCR via functional assays. This list of genes is provided by gene expression profiling of target cells known to stimulate the public TCR ('stimulator cells') verus non-stimulators, as well as from data in literature. In the second strategy (direct approach), in order to isolate or 'fish' the ligand from a strong stimulator cell line we plan to adopt several methods, such as: i) production of blocking antibodies, ii) generation of 'gd bodies', iii) proximity dependent biotinylation (BioID). The direct binding of promising ligand candidates with the public Vg8Vd1 TCR will be further investigated by surface plasmon resonance. Finally, in order to address the potential of this project for cancer immunotherapy we will evaluate the killing of primary cancer cells expressing the ligand by public Vg8Vd1-transduced PBMCs. The background of the MSCA applicant on HCMV-host interplay will highly complement the expertise of the group of David Vermijlen on gd T cells. As the public Vg8Vd1 TCR is present in every individual, the identification of its ligand will have broad implications as a possible target for the development of novel vaccination and cancer immunotherapy strategies.'
|year||authors and title||journal||last update|
David Vermijlen, Deborah Gatti, Ariadni Kouzeli, Teja Rus, Matthias Eberl
Î³Î´ T cell responses: How many ligands will it take till we know?
published pages: , ISSN: 1084-9521, DOI: 10.1016/j.semcdb.2017.10.009
|Seminars in Cell & Developmental Biology||2019-06-12|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GD TCR LIGAND" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "GD TCR LIGAND" are provided by the European Opendata Portal: CORDIS opendata.